US Broker Ratings

Semler Scientific, Inc. (SMLR) Stock Analysis: Unpacking the 206% Potential Upside for Investors

Semler Scientific, Inc. (NASDAQ: SMLR) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $372.73 million, this Santa Clara-based company is..

Personalis, Inc. (PSNL) Investor Outlook: Navigating a Tumultuous Market with Innovative Genomic Solutions

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly in diagnostics and research, with its cutting-edge cancer genomic tests and services. Even as the company grapples with..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unlocking a 25% Upside with Robust Revenue Growth

For investors looking to tap into the healthcare sector’s promise, Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents a compelling opportunity. This specialty pharmaceutical company is making significant strides in the development..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem with Over 100% Potential Upside

Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is captivating investor attention with its innovative approach to gene and cell therapy. Headquartered in Germantown, Maryland, this biopharmaceutical..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a 74.83% Potential Upside in Healthcare Tech

Investors looking for opportunities in the health information services sector may want to consider Weave Communications, Inc. (NYSE: WEAV). With a market capitalization of $503.05 million, Weave is carving out..

MeiraGTx Holdings plc (MGTX): Investor Outlook Reveals a Potential 215% Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its ambitious approach to genetic medicine. Specializing in innovative therapies for..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Exploring a 246.85% Potential Upside in Biotechnology

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector for its promising portfolio of therapies targeting autoimmune diseases and cancer. Based in Cambridge,..

Septerna, Inc. (SEPN) Stock Analysis: A 12.84% Upside Potential in the Biotechnology Sector

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company based in South San Francisco, California, is garnering attention for its innovative approach in addressing critical healthcare challenges. Operating within the healthcare..

Arvinas, Inc. (ARVN) Stock Analysis: Assessing an 81.27% Potential Upside in the Biotechnology Sector

Arvinas, Inc. (NASDAQ: ARVN) is a name that has been generating interest among investors, particularly in the healthcare sector, where innovation often leads to significant stock value appreciation. With a..

Trevi Therapeutics, Inc. (TRVI): Analyst Consensus Signals 84% Upside Potential

Investors eyeing the biotechnology sector may find Trevi Therapeutics, Inc. (NASDAQ: TRVI) a compelling prospect, particularly given the remarkable potential upside of 84.42% as identified by analysts. This clinical-stage biopharmaceutical..

Fortrea Holdings Inc. (FTRE) Investor Outlook: Navigating Challenges and Opportunities in the Biotechnology Sector

Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology sector, with its robust focus on providing innovative solutions for biopharmaceutical product and medical device development. As a contract..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a 98.97% Potential Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a U.S.-based biotechnology firm, has been generating buzz in the healthcare sector with its innovative approach to gene therapies targeting monogenic diseases of the..

Valneva SE (VALN) Stock Analysis: Exploring a 45% Potential Upside in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotech company, is making headlines in the healthcare sector with its strong revenue growth and promising pipeline of vaccines for infectious diseases. With a..

CorMedix Inc. (CRMD) Stock Analysis: A 67% Upside Potential with Strong Buy Ratings

CorMedix Inc. (CRMD), a biopharmaceutical company based in Berkeley Heights, New Jersey, is drawing significant attention from investors in the biotechnology sector. Specializing in the development and commercialization of therapeutic..

Cross Country Healthcare, Inc. (CCRN): Investor Outlook with a 53.80% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out in the healthcare sector, particularly within the medical care facilities industry. Headquartered in Boca Raton, Florida, the company specializes in providing essential..

Zenas BioPharma (ZBIO) Stock Analysis: Unpacking the 38.65% Potential Upside in the Biotech Space

Zenas BioPharma, Inc. (ZBIO) is capturing investor attention with its promising potential upside of 38.65%, according to recent analyst ratings. This clinical-stage biopharmaceutical company is making waves in the healthcare..

Claritev Corporation (CTEV): Investor Outlook Highlights 21% Potential Upside Amidst Growth in Healthcare Data Solutions

Investors looking for opportunities in the healthcare technology sector may find Claritev Corporation (NASDAQ: CTEV) an intriguing prospect. Specializing in data analytics and cost management solutions for the healthcare industry,..

Community Health Systems, Inc. (CYH): Investor Outlook on Healthcare Stock with Mixed Analyst Sentiment

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates an extensive network of medical facilities across the United States. Headquartered in Franklin, Tennessee, the company..

Xencor, Inc. (XNCR)

⚠️ No article content returned.

..

Altimmune, Inc. (ALT) Stock Analysis: A 304% Potential Upside Awaits Investors in the Biotech Arena

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, is grabbing investor attention with its promising pipeline and significant potential upside. Based in Gaithersburg, Maryland, Altimmune focuses on pioneering treatments for obesity,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds